Corpusense

Intuitive Surgical (ISRG) earnings call transcript summary & sentiment

Last call Thu 16 Jul 2026·Next Tue 20 Oct 2026

Our read on the 16 July 2026 earnings call

Overall tone: Positive

Overall tone

Positive

Executive Summary

Intuitive Surgical delivered strong second-quarter financial results, highlighted by 19% revenue growth to $2.89 billion and non-GAAP operating margin expansion to 42%. Total global procedure volume grew 16% YoY…

Core Signals

Revenue Growth & Demand: Total Q2 revenue grew 19% year-over-year to $2.89 billion, with recurring revenue representing 85% of total sales at $2.47 billion.

Bullish Signals

Total Q2 system placements increased 18% year-over-year to 468 units, led by robust customer adoption of DaVinci 5.

Risk Signals

U.S. da Vinci procedure growth decelerated to 12% in Q2 from 14% in Q1 due to patient deferrals in benign procedures.

Q&A Signals

Repeated analyst topics: Analysts repeatedly questioned management on the quantitative financial headwind from the 2027 Extended Use Program and the exact mechanics behind U.S. procedure growth moderation.

Key Investor Debate

The primary investor debate centers on whether the deceleration in U.S. procedure growth to 12% represents temporary friction from ACA subsidy changes or a structural slowdown caused by high market penetration and GLP-1 adoption.

Analyst Takeaway

Intuitive Surgical continues to demonstrate strong operational execution, backed by solid capital placement activity and an ecosystem business model generating 85% recurring revenue.

Those are the opening lines. The full read covers the whole earnings transcript: every bullish and bearish signal, what analysts pressed hardest on, and where management answered vaguely — each with the quote behind it. Every line sourced.

See the full Earnings Highlight

Themes across Intuitive Surgical and the Health Care sector

Analyse a theme over quarters — what's brand new, what's being talked about more, and what is spreading to more companies across the sector.

Unlock themes

Ask about Intuitive Surgical's earnings, or other S&P 500 earnings calls

Ask across the corpus, instead of reading one call at a time. Scope it to Intuitive Surgical, its sector, or every name we cover — plain English, no operators — and answers come back structured: a summary, the drivers, and a read on each company.

"What did Intuitive Surgical say about margins, and did the framing change from last quarter?"

"Did Intuitive Surgical's management walk back any full-year guidance, and how did they frame it?"

"Where did Intuitive Surgical avoid answering on capital allocation?"

Unlock search

Earnings call history & sentiment

Every one at 16:30 ET, after the close.

Date Day Period Corpusense read
2026-07-16Thursday2026 Q3Positive
2026-04-21Tuesday2026 Q2Positive
2026-01-22Thursday2026 Q1Positive
2025-10-21Tuesday2025 Q4—
2025-07-22Tuesday2025 Q3—
2025-04-22Tuesday2025 Q2—
2025-01-23Thursday2025 Q1—

Earnings calls across Health Care Equipment & Supplies

The companies Intuitive Surgical is read alongside. Each has its own earnings call dates and sentiment.

ABTAbbott LaboratoriesALGNAlign TechnologyBAXBaxter InternationalBDXBecton DickinsonBSXBoston ScientificCOOCooper Companies (The)DXCMDexcomEWEdwards Lifesciences

Intuitive Surgical is one of the S&P 500 companies we track

Sentiment analysis on any single earnings call, themes building across a sector, and search across every company and quarter — each claim linked back to the passage it came from.

Create a free account See the full calendar Plans & pricing